---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-013970"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2021-07-19T23:59:59+00:00"
generated_at: "2026-06-30T04:29:46.730867+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Aurinia voluntarily delists from TSX effective July 30, 2021; continues on Nasdaq

## Summary
- Delisting from Toronto Stock Exchange effective July 30, 2021; no shareholder approval required.
- Nasdaq accounted for ~94% of daily trading volume over past 12 months.
- Dual listing costs and administrative burden no longer justified given low TSX volume.
- Common shares continue trading on Nasdaq under ticker AUPH.
- Canadian brokers can trade Nasdaq-listed shares; shareholder value unaffected.

## SEC filing metadata
- accession: 0001628280-21-013970
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2021-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000162828021013970/0001628280-21-013970-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000162828021013970/auph-20210716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-013970
- JSON: https://secwatch.observer/filing/0001628280-21-013970.json
- Plain text: https://secwatch.observer/filing/0001628280-21-013970.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.